Role of 5-hydroxytryptamine3 (5-HT3) antagonists in the prevention of emesis caused by anticancer therapy
- 13 September 1996
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 52 (5) , 685-692
- https://doi.org/10.1016/0006-2952(96)00346-2
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The physiology and pharmacology of postoperative nausea and vomitingAnaesthesia, 1994
- A proposed new nomenclature for 5-HT receptorsTrends in Pharmacological Sciences, 1993
- Clinical evaluation of 5-HT3 receptor antagonists as anti-emeticsTrends in Pharmacological Sciences, 1991
- Primary Structure And Functional Expression of the 5HT 3 Receptor, A Serotonin-gated Ion ChannelScience, 1991
- Solubilisation of the 5‐Hydroxytryptamine3 Receptor from Pooled Rat Cortical and Hippocampal MembranesJournal of Neurochemistry, 1990
- The role of receptor subtype diversity in the CNSTrends in Neurosciences, 1990
- 5-HT3 receptors are membrane ion channelsNature, 1989
- Electrophysiology of 5-HT3 receptors in neuronal cell linesTrends in Pharmacological Sciences, 1989
- Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cellsNeuropharmacology, 1988
- The pharmacology and function of 5-HT3receptorsTrends in Neurosciences, 1986